Signaling new therapeutic opportunities: cytokines in prostate cancer.
Elias B A ChandranLuke MeiningerFatima KarzaiRavi A MadanPublished in: Expert opinion on biological therapy (2022)
Cytokine-based therapies present an alternative immune strategy to target the pleiotropic prostate cancer tumor microenvironment beyond T-cells. Future immunotherapy strategies in prostate cancer should address these immune cell populations, which may play more important roles in the prostate cancer tumor microenvironment.
Keyphrases